Construction projects on campus

Städtebaulicher Wettbewerb

In the coming years the science and biotech campus will be expanded significantly. New institutes, various labs, an in vivo pathophysiology lab and buildings for companies will be constructed. Technology platforms also need to be extended. In particular, the infrastructure of the northern part of the Campus needs to be adapted and renewed. In the spring of 2010 an urban design and landscape planning competition took place on campus. The result was a future-oriented concept for the capital city region of Berlin-Brandenburg that will meet the high standards of excellence of a leading science and business location.

Figure: Entwurf der sinai - Gesellschaft von Landschaftsarchitekten mbH

BerlinBioCube - Start-up Center

BerlinBioCube - Start-up Center

Campus Berlin-Buch GmbH (CBB) is building the new life science start-up center BerlinBioCube on the Berlin-Buch campus from 2020. The CBB operates and develops the research and biotech campus in Berlin-Buch, which focuses on biomedicine. The spectrum of the BiotechPark Berlin-Buch includes medical biotechnology, medical technology and related areas. In the BerlinBioCube, more jobs can now be created in innovative areas of the healthcare industry.

Civil engineering work is scheduled to start in September 2020. The BerlinBioCube will offer a total of 8,000 square meters of space on five floors for modern laboratories, offices, communal areas for daily encounters and exchange as well as conference rooms. Young start-ups can move into the new BiotechPark Berlin-Buch building as early as 2023 and benefit from the very good conditions that the campus offers. The building was designed by the architecture office doranth post architects, Munich. The new building of the BerlinBioCube involves an investment of 55 million euros, of which around 40 percent will go into the technical equipment. The financing is made possible by funds from the joint task "Improvement of the regional economic structure" (GRW).

With 61 companies, 800 employees and around 31,000 square meters of office and laboratory space, the BiotechPark Berlin-Buch is one of the leading technology parks in Germany. Spin-offs in the life sciences sector will find ideal conditions here, from technology transfer to industry-specific laboratory and office space. The local life science community enables direct exchange and joint projects. The BiotechPark makes a major contribution to the dynamic development of the Berlin-Brandenburg biotechnology region and particularly strengthens the industrial health economy.

Fig.: doranth post architects

 

BIH research building

BIH research building

MDC and BIH erect a new research facility for physicians, researchers and patients. The Käthe Beutler building will be completed in 2020.

Two old campus hospital buildings from the seventies will give way for a new research facility. The MDC, the Berlin Institute for Health (BIH), and the Charité – Universitätsmedizin Berlin raise the structure at Lindenberger Weg 80 as a new central site of the BIH. It will be named after Käthe Beutler, a Berlin paediatrician who fled from the Nazis in 1935.

Three plane trees in front of the site were already trimmed to protect them from damage during the demolition works. From September onwards, the old houses will be torn down and excavators will be lifting a pit. In February 2018, the two-year construction period of the new building begins. Once complete, 135 scientists from basic and clinical research, as well as doctors will work under a single roof.

A small cafeteria in the publicly-accessible entrance area of ​​the Käthe Beutler building will be open to all visitors and employees. By the end of 2019, the bus will stop right outside the doorway of the new building. At the moment, it is still stopping on the campus to serve the outpatient clinics.

www.mdc-berlin.de

Forschungseinrichtung experimentelle Medizin (FEM)

Forschungseinrichtung experimentelle Medizin (FEM)

The "Forschungseinrichtung experimentelle Medizin" (FEM) is being built on the Berlin Buch campus as part of the building master plan of the Charité - Universitätsmedizin Berlin, which will replace a technically obsolete animal house that is in great need of renovation. The construction measure includes a joint infrastructure building (ISG), which is being built in cooperation with the Max Delbrück Center for Molecular Medicine (MDC). With 20,400 square meters, the new building offers sufficient space for the most modern and gentle examination procedures; especially for imaging processes such as ultrasound and magnetic resonance tomography (MRT). The new building will be completed in 2020.

(Fig.: Heinle, Wischer und Partner, Free Architects)

Preclinical Research Center (PRC)

Preclinical Research Center (PRC)

Construction of the Preclinical Research Center (PRC) on the Berlin-Buch campus began at the beginning of 2015. The PRC is a replacement building for an older animal house of the Max Delbrück Center for Molecular Medicine and will provide space for 4,000 mouse and rat cages or around 12,000 animals. Laboratory rooms will also be created in the building. The main focus of the animal experiments in PCR will be on minimally invasive, i.e. less stressful, methods. These include, for example, the most modern imaging methods such as magnetic resonance tomography or PET scans. 24 million euros from federal and state grants will flow into the construction project; of which ten million euros from the MDC. Completion will take place in 2020.

Fig.: doranth post architects

News Buch Berlin

Eckert & Ziegler Acquires 53,000 Square Feet Facility for Expansion of Contract Development and Manufacturing Services

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) has received from the Berlin City Government a 66-year long-term lease for an industrial property with 53,000 square feet (...

more ...

Lighting up tumor cells

MDC PhD student Matthias Jürgen Schmitt is being honored with the Curt Meyer Memorial Prize of the Berlin Cancer Society for his achievements in cancer research. He employs molecular reporters to inve...

more ...

Nantes University Hospital Doses First Patients with Eckert & Ziegler’s Novel Ga-68 Imaging Agent PENTIXAFOR

PENTIXAFOR is an innovative imaging compound for the initial staging of cancer patients with symptomatic multiple myelomas. The Ga-68 based radio-diagnostic promises to significantly improve the patie...

more ...

Events Buch Berlin

08.11.2021, 09:00
Weiterbildungskurs: Fachkraft für Molekularbiologie (TÜV) vom 8. - 19. November 2021

Das 11-tägige Intensiv-Seminar vermittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschung. Nutzen Sie auch die Gele...

more ...

09.11.2021, 16:00
Vortrag: "SARS-Cov-2-Forschung: Zellveränderungen bei Infektion und daraus entstehende unterschiedliche Krankheitsverläufe"

Referent: Dr. Emanuel Wyler, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC)/BIMSB

more ...

22.11.2021, 15:00
VORLESUNGSREIHE "NEUE WEGE IN DER BIOMEDIZIN": Neues aus der Hirnforschung

Themen sind Esssörungen und Multiple Sklerose

more ...

This website is supported by: